PHI with Chronic active hepatitis
How does this condition affect your private health insurance?
Chronic aggressive hepatitis refers to a severe, persistent inflammation of the liver characterized by ongoing liver cell damage, inflammation, and progressive fibrosis. This condition, often autoimmune or caused by chronic viral infections like Hepatitis B or C, significantly impairs liver function. Patients may experience symptoms ranging from profound fatigue and jaundice to more severe manifestations such as ascites, variceal bleeding, and hepatic encephalopathy as the disease advances to cirrhosis and liver failure. Without effective management, the aggressive nature of the inflammation rapidly accelerates liver damage, leading to life-threatening complications. Early and sustained treatment is vital to slow progression, prevent irreversible damage, and improve long-term outcomes for individuals affected by this serious liver disease.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for symptomatic presentation or acute exacerbation.
Duration of Illness (Lifetime)
Chronic, lifelong without cure or successful transplantation.
Cost of Treatment (Initial)
High (e.g., 5,000 to 50,000 USD for initial diagnosis and acute management, depending on the healthcare system and severity).
Cost of Treatment (Lifetime)
Very High (e.g., 100,000 to over 1,000,000 USD, including long-term medication, monitoring, managing complications, and potential liver transplant).
Mortality Rate
Moderate to High (e.g., 20-50% over 5-10 years without effective treatment, higher with advanced complications like liver failure or hepatocellular carcinoma).
Risk of Secondary Damages
Very High (e.g., 80-95% for progression to cirrhosis, liver failure, or hepatocellular carcinoma without effective management; also significant psychological impact).
Probability of Full Recovery
Low (e.g., less than 10-20% for spontaneous complete recovery; remission with treatment is possible but often requires lifelong therapy and may not be considered complete recovery without consequences).
Underlying Disease Risk
Moderate (e.g., 30-50% for other autoimmune conditions if autoimmune hepatitis, or co-infections with other viruses if viral hepatitis is the cause).